{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:06:19Z","timestamp":1791515179427,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012416","name":"Inova Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.aohep.2021.100556","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T21:37:04Z","timestamp":1637185024000},"page":"100556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C"],"prefix":"10.1016","volume":"27","author":[{"given":"Pegah","family":"Golabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Eberly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"de Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2021.100556_bib0001","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100556_bib0002","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0003","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-019-05537-2","article-title":"Disease Burden of Hepatocellular Carcinoma: A Global Perspective","author":"Sayiner","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2021.100556_bib0004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and Management of Hepatocellular Carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100556_bib0005","first-page":"287","article-title":"Hepatitis C virus infection and its rheumatologic implications","volume":"10","author":"Sayiner","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0006","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cld.2017.03.010","article-title":"Dermatologic Manifestations of Chronic Hepatitis C Infection","volume":"21","author":"Sayiner","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.aohep.2021.100556_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-020-10038-w","article-title":"Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population","author":"Sayiner","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100556_bib0008","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2021.100556_bib0009","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/liv.14305","article-title":"Increased cancer rates in patients with chronic hepatitis C","volume":"40","author":"Nyberg","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2021.100556_bib0010","article-title":"Mortality Related to Non-Alcoholic Fatty Liver Disease is Increasing in the United States over the Last Decade","author":"Paik","year":"2021","journal-title":"Hepatology Communications n.d"},{"key":"10.1016\/j.aohep.2021.100556_bib0011","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2021.100556_bib0012","unstructured":"Kochanek KD, Murphy SL, Xu J, Arias E. Deaths: final data for 2017 2019."},{"key":"10.1016\/j.aohep.2021.100556_bib0013","first-page":"1","article-title":"Mortality in the United States","volume":"2018","author":"Murphy","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.aohep.2021.100556_bib0014","article-title":"National Vital Statistics System, Centers for Disease Control and Prevention","year":"2018","journal-title":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.aohep.2021.100556_bib0015","article-title":"Vital statistics of the United States: Mortality, 1999. Technical appendix. Hyattsville, MD. 2004","year":"2021","journal-title":"National Center for Health Statistics n.d"},{"key":"10.1016\/j.aohep.2021.100556_bib0016","unstructured":"International statistical classification of diseases and related health problems. 10th revision. Volume 2. Instruction manual. Geneva: World Health Organization; 2011. World Health Organization 2011. http:\/\/www.who.int\/classifications\/icd\/ICD10Volume2_en_2010.pdf (accessed October 19, 2020)."},{"key":"10.1016\/j.aohep.2021.100556_bib0017","doi-asserted-by":"crossref","unstructured":"Paik JM, Henry L, Golabi P, Alqahtani SA, Trimble G, Younossi ZM. Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016. Open Forum Infect Dis 2020;7:ofz509. 10.1093\/ofid\/ofz509.","DOI":"10.1093\/ofid\/ofz509"},{"key":"10.1016\/j.aohep.2021.100556_bib0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12876-019-0972-6","article-title":"Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States","volume":"19","author":"Golabi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100556_bib0019","unstructured":"National Center for Health Statistics. International statistical classification of diseases and related health problems. Tabular list, 2017. (Modified by the National Center for Health Statistics for use in the classification and analysis of medical mortality data in the U.S.) NCHS Instruction Manual; part 2e, vol 1. Hyattsville, MD 2017. https:\/\/www.cdc.gov\/nchs\/data\/dvs\/2e_volume1_2017.pdf."},{"key":"10.1016\/j.aohep.2021.100556_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0022","article-title":"Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis","author":"Moon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0023","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/j.gastro.2018.07.008","article-title":"Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016","volume":"155","author":"Kim","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100556_bib0024","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","article-title":"Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100556_bib0025","doi-asserted-by":"crossref","first-page":"e0214","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.aohep.2021.100556_bib0026","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/dc14-1239","article-title":"Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD","volume":"38","author":"Bazick","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2021.100556_bib0027","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100556_bib0028","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100556_bib0029","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100556_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jceh.2019.06.007","article-title":"Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965","volume":"10","author":"Shirazi","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0031","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep4.1387","article-title":"Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease","volume":"3","author":"Golabi","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2021.100556_bib0032","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0033","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s12072-019-09995-8","article-title":"Hepatocellular carcinoma and non-alcoholic fatty liver disease","volume":"13","author":"Golabi","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100556_bib0034","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCG.0000000000001172","article-title":"Among Medicare Patients With Hepatocellular Carcinoma, Non\u2013alcoholic Fatty Liver Disease is the Most Common Etiology and Cause of Mortality","volume":"54","author":"Hester","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100556_bib0035","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep4.1599","article-title":"The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2021.100556_bib0036","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/acer.12887","article-title":"Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States","volume":"39","author":"Guirguis","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.aohep.2021.100556_bib0037","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MCG.0000000000000161","article-title":"Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States","volume":"49","author":"Jinjuvadia","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100556_bib0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/TP.0000000000002471","article-title":"Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States","volume":"103","author":"Cholankeril","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.aohep.2021.100556_bib0039","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.cgh.2015.08.015","article-title":"Current and Future Burden of Chronic Nonmalignant Liver Disease","volume":"13","author":"Udompap","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0041","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2018.08.013","article-title":"The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options","volume":"69","author":"Younossi","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100556_bib0042","doi-asserted-by":"crossref","DOI":"10.2174\/1381612826666200303114934","article-title":"Epidemiology of Non-alcoholic Fatty Liver Disease in North America","author":"Arshad","year":"2020","journal-title":"Curr Pharm Des"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:43:23Z","timestamp":1761648203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268121002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1665268121002556"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100556","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100556"}}